Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Juniper berries contain volatile oils, particularly terpinen-4-ol, which directly irritate kidney tubules to increase glomerular filtration and urine output. This direct renal stimulation distinguishes juniper from other herbal diuretics. The berries also contain flavonoids that may support this diuretic effect. Evidence level C supports this traditional use. However, this same mechanism explains why prolonged use can cause kidney irritation, making it important to limit use to 2-4 weeks maximum.
Does juniper berry interact with any medications?
Juniper may interact with diuretic medications, potentially enhancing their effects and increasing the risk of dehydration and electrolyte imbalances. Due to potential effects on blood sugar, juniper may interact with diabetes medications, requiring careful monitoring. The herb may also interact with lithium, as increased urination can affect lithium clearance from the body. Those taking prescription medications should consult a healthcare provider before using juniper supplements.
What is the recommended dosage for juniper berry?
For adults, the typical dosage is 1-2 cups of juniper berry tea daily, prepared by steeping crushed dried berries in hot water. Alternatively, 1-2ml of tincture can be taken three times daily. Commission E has approved juniper for dyspeptic complaints at these levels. Use should be limited to 2-4 weeks maximum due to the risk of kidney irritation with prolonged use. Dosage for children has not been established and is not recommended.
Is juniper berry safe during pregnancy and breastfeeding?
Juniper berry is considered unsafe during pregnancy due to its uterine stimulant properties, which may cause miscarriage or premature labor. The volatile oils can cross the placenta and potentially harm the developing fetus. Breastfeeding women should also avoid juniper as insufficient safety data exists. Women who are pregnant, trying to conceive, or breastfeeding should consult their healthcare provider for safe alternatives for digestive or urinary complaints.
What are juniper berries used for medicinally?
Juniper berries have been used traditionally for digestive complaints, urinary tract conditions, and rheumatic pain. Commission E has approved juniper for dyspeptic complaints based on its carminative properties, which help relieve gas and bloating. The berries also demonstrate antimicrobial and diuretic activity. Evidence level C supports these uses, meaning they are primarily based on traditional use and pharmacological rationale rather than extensive clinical trials.
What are the side effects of juniper berry?
The primary concern with juniper berry is kidney irritation, which can occur with prolonged use or high doses. This is due to the irritant nature of the volatile oils on kidney tissue. Other potential side effects include gastrointestinal upset in sensitive individuals. Juniper should not be used by those with acute kidney inflammation or kidney disease. If you experience changes in urination, kidney pain, or other concerning symptoms, discontinue use and seek medical attention.
Fiche d'information compilée à partir de PubMed
Cette fiche a été compilée à partir de résumés PubMed (NIH) avec l'assistance d'une IA. Chaque affirmation factuelle est citée par un article PubMed réel (voir la liste des sources). Elle n'a pas encore été révisée par un humain — confirmez auprès d'un professionnel de santé avant utilisation.
Compilé à partir de 30 articles PubMed · modèle : gemma4:31b
Résumé
Juniperus communis is an evergreen shrub or tree native to the Northern Hemisphere, used traditionally in phytotherapy for various biomedical applications [PMID:11558640, 27419205, 39599442].
Contexte
Common juniper (Juniperus communis L.) is a gymnosperm of the Cupressaceae family found in Europe, Asia, and North America [PMID:11558640, 27419205, 39599442]. It is characterized by fleshy, spherical female cones known as berries [PMID: 39599442].
Usages traditionnels
Traditionally used to treat renal suppression, acute and chronic cystitis, bladder catarrh, albuminuria, leucorrhea, amenorrhea [PMID: 35328621], skin diseases [PMID: 27492585], and as an antidiarrhoeal, anti-inflammatory, astringent, and antiseptic for various abdominal disorders [PMID: 27419205].
Composés actifs
The plant contains phenolics, terpenoids, organic acids, alkaloids, and volatile compounds [PMID: 35328621]. Specific constituents include monoterpenes (α-pinene, β-pinene, sabinene, limonene, myrcene), sesquiterpenes, polysaccharides, steroids, fatty acid esters, biflavonoids (such as hypolaetin 7-O-β-xylopyranoside), and apigenin [PMID: 26784665, 27419205, 27492585, 37836145].
Mécanisme d'action
Compounds from J. communis exhibit tyrosinase inhibition, specifically hypolaetin 7-O-β-D-xylopyranoside which suppresses α-MSH-induced melanin synthesis [PMID: 27492585]. Other reported activities include antioxidant, anti-inflammatory, and antimicrobial effects [PMID: 39599442].
Preuves cliniques
Preuve BPrimary Dysmenorrhea
Juniper berry (750 mg capsules thrice daily) was evaluated for efficacy and safety regarding pain intensity and quality of life compared to mefenamic acid [PMID: 39842749]
Preuve BFunctional Dyspepsia
A standardized juniper oil preparation (Roleca® Juniper 100 mg) was tested in a placebo-controlled trial to evaluate efficacy and safety in adults [PMID: 41240546]
Preuve DColon Carcinogenesis (Rat Model)
Juniper berry oil (100 μl/kg) significantly decreased the number and size of adenomas and adenocarcinomas in AOM-induced colon cancer rats [PMID: 31617778]
Sécurité et effets indésirables
A case report describes bullous dermatitis caused by common juniper [PMID: 32712995]. In animal feed, EFSA concluded safety at specific concentrations (e.g., 4-20 mg/kg depending on species) [PMID: 37089171].
Synthèse des preuves
Evidence ranges from traditional use and in vitro/animal studies (antioxidant, antimicrobial, and anticancer activities) to recent double-blind RCTs for functional dyspepsia and primary dysmenorrhea.
2.PMID: 28401436 (2019) — Cypress Pollinosis: from Tree to Clinic. · Clinical reviews in allergy & immunology
3.PMID: 11558640 (2001) — Final report on the safety assessment of Juniperus communis Extract, Juniperus oxycedrus Extract, Juniperus oxycedrus Tar, Juniperus phoenicea extract, and Juniperus virginiana Extract. · International journal of toxicology
4.PMID: 37241749 (2023) — Assessment of the Use of Common Juniper (Juniperus communis L.) Foliage following the Cascade Principle. · Molecules (Basel, Switzerland)
5.PMID: 35328621 (2022) — Zimbro (Juniperus communis L.) as a Promising Source of Bioactive Compounds and Biomedical Activities: A Review on Recent Trends.
Sources gouvernementales
Aucune monographie gouvernementale directe n'est disponible pour cette plante. Le contenu ci-dessous est généré par IA et n'a pas été vérifié par rapport à une source gouvernementale faisant autorité. Utilisez les liens de recherche pour consulter les sources officielles avant de vous fier à ces informations.
6.PMID: 27492585 (2016) — Tyrosinase inhibitory flavonoid from Juniperus communis fruits. · Bioscience, biotechnology, and biochemistry
7.PMID: 31617778 (2021) — Chemopreventive efficacy of juniper berry oil (Juniperus communis L.) on azoxymethane-induced colon carcinogenesis in rat. · Nutrition and cancer
8.PMID: 37089171 (2023) — Safety and efficacy of feed additives consisting of an essential oil and tincture from the berries of Juniperus communis L. (juniper oil and juniper tincture) for use in all animal species (FEFANA asbl). · EFSA journal. European Food Safety Authority
9.PMID: 37836145 (2023) — Comparative Analysis of Chemical Profile and Biological Activity of Juniperus communis L. Berry Extracts. · Plants (Basel, Switzerland)
10.PMID: 32712995 (2020) — Bullous dermatitis caused by common juniper. · Contact dermatitis
11.PMID: 39599442 (2024) — Beyond Essential Oils: Diterpenes, Lignans, and Biflavonoids from Juniperus communis L. as a Source of Multi-Target Lead Compounds. · Plants (Basel, Switzerland)
12.PMID: 39842749 (2025) — Efficacy and safety of abhal (Juniperus communis L). on pain intensity, uterine artery doppler flow, and quality of life in primary dysmenorrhea: A double-blind, randomized controlled trial. · Journal of ethnopharmacology
13.PMID: 41240546 (2025) — Efficacy and safety of Roleca® juniper 100 mg in the treatment of functional dyspepsia: A randomized, double-blind, placebo-controlled trial. · Phytomedicine : international journal of phytotherapy and phytopharmacology
14.PMID: 27419205 (2014) — A Phytopharmacological Review on a Medicinal Plant: Juniperus communis. · International scholarly research notices
15.PMID: 29266487 (2018) — Antiadhesion activity of juniper (Juniperus communis L.) preparations against Campylobacter jejuni evaluated with PCR-based methods. · Phytotherapy research : PTR
16.PMID: 26784665 (2014) — Chemical Composition and Antioxidant Properties of Juniper Berry (Juniperus communis L.) Essential Oil. Action of the Essential Oil on the Antioxidant Protection of Saccharomyces cerevisiae Model Organism. · Antioxidants (Basel, Switzerland)